Literature DB >> 23731694

Nicotine enhances ethanol-induced fat accumulation and collagen deposition but not inflammation in mouse liver.

Yongke Lu1, Stephen C Ward, Arthur I Cederbaum.   

Abstract

INTRODUCTION: Alcohol and tobacco are frequently co-abused. Tobacco smoke increases alcoholic steatosis in apoE(-/-) mice. Tobacco smoke contains more than 4000 chemicals, but it is unknown which compounds in tobacco smoke play a major role in increasing alcoholic steatosis.
METHODS: C57BL/J6 mice were intraperitoneally injected with nicotine at 1 mg/kg every day or saline at the same volume as a control and the mice were fed dextrose-control or ethanol Lieber-DeCarli liquid diets. Three weeks later the mice were sacrificed after overnight fasting.
RESULTS: Neither nicotine injection nor ethanol feeding alone increased serum levels of triglyceride, but the combination of nicotine and ethanol increased serum levels of triglyceride. Both nicotine injection alone and ethanol feeding alone increased hepatic collagen type I deposition, and nicotine injection and ethanol feeding combined further increased hepatic collagen type I deposition. The combination of nicotine and ethanol also activated hepatic stellate cells, a principal liver fibrogenic cell. Hepatic fat accumulation was induced by ethanol feeding, which was further enhanced by nicotine injection. Ethanol feeding caused an increase in serum ALT, but nicotine did not further increase serum ALT levels. Lipid droplets and inflammatory foci were observed in liver sections from ethanol-fed mice; nicotine treatment increased the number and size of lipid droplets, but not the number and size of inflammatory foci. Nicotine did not further increase ethanol-induced hepatic neutrophil infiltration.
CONCLUSIONS: These results suggest that nicotine enhances ethanol-induced steatosis and collagen deposition, but nicotine has no effect on ethanol-induced inflammation.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23731694      PMCID: PMC3723131          DOI: 10.1016/j.alcohol.2013.04.004

Source DB:  PubMed          Journal:  Alcohol        ISSN: 0741-8329            Impact factor:   2.405


  35 in total

Review 1.  Neuronal nicotinic receptors: from protein structure to function.

Authors:  V Itier; D Bertrand
Journal:  FEBS Lett       Date:  2001-08-31       Impact factor: 4.124

Review 2.  Decreasing smoking behaviour and risk through CYP2A6 inhibition.

Authors:  Edward M Sellers; Rachel F Tyndale; Leona C Fernandes
Journal:  Drug Discov Today       Date:  2003-06-01       Impact factor: 7.851

3.  Depot fat as source of increased liver triglycerides after ethanol.

Authors:  M G HORNING; E A WILLIAMS; H M MALING; B B BRODIE
Journal:  Biochem Biophys Res Commun       Date:  1960-12       Impact factor: 3.575

4.  Cotinine binding to nicotinic acetylcholine receptors in bovine chromaffin cell and rat brain membranes.

Authors:  P J Vainio; R K Tuominen
Journal:  Nicotine Tob Res       Date:  2001-05       Impact factor: 4.244

5.  Smoking vs other risk factors as the cause of smoking-attributable deaths: confounding in the courtroom.

Authors:  M J Thun; L F Apicella; S J Henley
Journal:  JAMA       Date:  2000-08-09       Impact factor: 56.272

6.  Additive effects of nicotine and high-fat diet on hepatic steatosis in male mice.

Authors:  Theodore C Friedman; Indrani Sinha-Hikim; Meher Parveen; Sonia M Najjar; Yanjun Liu; Michael Mangubat; Chang-Sung Shin; Alexei Lyzlov; Rasheed Ivey; Magda Shaheen; Samuel W French; Amiya P Sinha-Hikim
Journal:  Endocrinology       Date:  2012-10-23       Impact factor: 4.736

7.  Metabolic effects of nicotine on human adipose tissue in organ culture.

Authors:  T Chajek-Shaul; G Scherer; V Barash; E Shiloni; Y Caine; O Stein; Y Stein
Journal:  Clin Investig       Date:  1994-01

8.  The expression and functional role of nicotinic acetylcholine receptors in rat adipocytes.

Authors:  Run-Hua Liu; Masanari Mizuta; Shigeru Matsukura
Journal:  J Pharmacol Exp Ther       Date:  2004-03-01       Impact factor: 4.030

9.  Cholinoceptor-mediated effects on glycerol output from human adipose tissue using in situ microdialysis.

Authors:  K Andersson; P Arner
Journal:  Br J Pharmacol       Date:  1995-08       Impact factor: 8.739

Review 10.  Regulation of the cytochrome P450 2A genes.

Authors:  Ting Su; Xinxin Ding
Journal:  Toxicol Appl Pharmacol       Date:  2004-09-15       Impact factor: 4.219

View more
  8 in total

Review 1.  Alcoholic Liver Disease: from CYP2E1 to CYP2A5.

Authors:  Tung Ming Leung; Yongke Lu
Journal:  Curr Mol Pharmacol       Date:  2017       Impact factor: 3.339

2.  Suppressed hepatocyte proliferation via a ROS-HNE-P21 pathway is associated with nicotine- and cotinine-enhanced alcoholic fatty liver in mice.

Authors:  Xue Chen; Kesheng Wang; Arthur I Cederbaum; Yongke Lu
Journal:  Biochem Biophys Res Commun       Date:  2019-03-12       Impact factor: 3.575

3.  Alcohol Upregulation of CYP2A5: Role of Reactive Oxygen Species.

Authors:  Yongke Lu; Arthur I Cederbaum
Journal:  React Oxyg Species (Apex)       Date:  2016-03

Review 4.  Cytochrome P450s and Alcoholic Liver Disease.

Authors:  Yongke Lu; Arthur I Cederbaum
Journal:  Curr Pharm Des       Date:  2018       Impact factor: 3.116

5.  Nicotine enhances alcoholic fatty liver in mice: Role of CYP2A5.

Authors:  Xue Chen; Emmanuel Owoseni; Julia Salamat; Arthur I Cederbaum; Yongke Lu
Journal:  Arch Biochem Biophys       Date:  2018-09-15       Impact factor: 4.013

6.  Hepatic and renal damage by alcohol and cigarette smoking in rats.

Authors:  Solange Bandiera; Rianne R Pulcinelli; Fernanda Huf; Felipe B Almeida; Graziele Halmenschlager; Paula E R Bitencourt; Eliane Dallegrave; Marilda C Fernandes; Rosane Gomez; Mauricio S Nin
Journal:  Toxicol Res       Date:  2020-08-13

7.  PPARα agonist WY-14,643 enhances ethanol metabolism in mice: Role of catalase.

Authors:  Xue Chen; Yunhui Xu; Krista L Denning; Audrey Grigore; Yongke Lu
Journal:  Free Radic Biol Med       Date:  2021-04-20       Impact factor: 8.101

8.  Downregulation of FHOD1 Inhibits Metastatic Potential in A549 Cells.

Authors:  Marta Hałas-Wiśniewska; Magdalena Izdebska; Wioletta Zielińska; Alina Grzanka
Journal:  Cancer Manag Res       Date:  2021-01-08       Impact factor: 3.989

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.